{"id":21774,"date":"2023-09-08T09:00:03","date_gmt":"2023-09-08T13:00:03","guid":{"rendered":"https:\/\/medicarereport.org\/?p=21774"},"modified":"2023-09-08T09:00:04","modified_gmt":"2023-09-08T13:00:04","slug":"how-the-drug-price-negotiation-program-could-affect-medicare-part-d-beneficiaries","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=21774","title":{"rendered":"How the drug price negotiation program could affect Medicare Part D beneficiaries"},"content":{"rendered":"\n<p>By Mariana Socal for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much has been discussed about the drugs that were selected and the magnitude of price decreases that can be achieved. Less attention has been given to what this all means for Medicare beneficiaries.  Continue reading <a href=\"https:\/\/www.statnews.com\/2023\/09\/08\/medicare-part-d-drug-price-negotiations\/\" data-type=\"link\" data-id=\"https:\/\/www.statnews.com\/2023\/09\/08\/medicare-part-d-drug-price-negotiations\/\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"225\" height=\"24\" class=\"wp-image-4372\" style=\"width: 225px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 225px) 100vw, 225px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Mariana Socal for STAT) After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,20,15],"tags":[385,400,65],"class_list":["post-21774","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-health-care-redesign","category-part-dprescription-drugs","tag-healthcare-costs","tag-medicare-drug-price-negotiation-program","tag-medicare-part-d"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21774"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21774\/revisions"}],"predecessor-version":[{"id":21775,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21774\/revisions\/21775"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}